Norgestimate
Norgestimate|
|
| Systematic (IUPAC) name |
|---|
|
(13-ethyl-17-ethynyl-3-hydroxyimino- 1,2,6,7,8,9,10,11,12,14,15,16- dodecahydrocyclopenta[a] phenanthren-17-yl) acetate |
| Clinical data |
|---|
| AHFS/Drugs.com |
Micromedex Detailed Consumer Information |
|---|
| MedlinePlus |
a601050 |
|---|
| Legal status |
|---|
| Legal status |
|
|---|
| Pharmacokinetic data |
|---|
| Biological half-life |
12–30 hours |
|---|
| Identifiers |
|---|
| CAS Number |
35189-28-7 Y |
|---|
| ATC code |
G03AA11 (WHO) G03FA13 (only combinations with estrogens) |
|---|
| PubChem |
CID 6540478 |
|---|
| IUPHAR/BPS |
7091 |
|---|
| DrugBank |
DB00957 Y |
|---|
| ChemSpider |
5022837 Y |
|---|
| UNII |
C291HFX4DY Y |
|---|
| KEGG |
D05209 Y |
|---|
| ChEBI |
CHEBI:50815 Y |
|---|
| ChEMBL |
CHEMBL1200934 N |
|---|
| Chemical data |
|---|
| Formula |
C23H31NO3 |
|---|
| Molar mass |
369.497 g/mol |
|---|
O=C(O[C@@]2(C#C)CC[C@H]1[C@H]4[C@H](CC[C@@]12CC)[C@@H]3/C(=C\C(=N\O)CC3)CC4)C
|
InChI=1S/C23H31NO3/c1-4-22-12-10-19-18-9-7-17(24-26)14-16(18)6-8-20(19)21(22)11-13-23(22,5-2)27-15(3)25/h2,14,18-21,26H,4,6-13H2,1,3H3/b24-17+/t18-,19+,20+,21-,22-,23-/m0/s1 YKey:KIQQMECNKUGGKA-NMYWJIRASA-N Y
|
N Y (what is this?) (verify) |
|---|
Norgestimate (INN, USAN, BAN) is an acetylated progestin used as an oral contraceptive.[1] It acts as a prodrug to norelgestromin (17-deacetylnorgestimate or levonorgestrel 3-oxime), the primary active metabolite, and levonorgestrel (deacetylation of norgestimate occurs in the intestines and the liver).[1] Unlike levonorgestrel, norgestimate shows high selectivity for the progesterone receptor and low androgenic action due to a large drug-induced elevation in the level of sex hormone-binding globulin (SHBG) (which preferentially binds androgens and thus inhibits their action).[1][2] In accordance, clinical trials have observed minimal androgenic side effects.[2] Norgestimate and its metabolites themselves, unlike many other progestins, do not bind to SHBG.[1] Norgestimate is used in combination with ethinyl estradiol as an oral contraceptive.[3]
See also
References
|
|---|
| Receptor (ligands) | | Agonists | |
|---|
| | |
|---|
| Antagonists |
- 3α-Hydroxytibolone
- 3β-Hydroxytibolone
- Aglepristone
- Lilopristone
- Lonaprisan
- Onapristone
- Toripristone
- Valproic acid
- Vilaprisan
- ZM-150,271
- ZM-172,406
|
|---|
|
|---|
|
|---|
| | Enzyme | |
|---|
| | Others | Precursors/prohormones | |
|---|
| Indirect |
- Antigonadotropins (e.g., estrogens, progestogens, prolactin)
- GnRH agonists (e,g, GnRH, leuprorelin)
- GnRH antagonists (e.g., cetrorelix)
- Gonadotropins (e.g., FSH, hCG, LH)
- Kisspeptin
- Plasma proteins (ABP, albumin, SHBG)
|
|---|
|
|---|
| See also: Androgenics • Estrogenics • Glucocorticoids • Mineralocorticoids |
|